Pharmaceuticals
Pfizer’s Lung Cancer Drug Lorbrena Shows Promising Long-Term Results
Potential New Standard Treatment for Advanced ALK-Positive Lung Cancer Pfizer's (PFE) drug Lorbrena has demonstrated promising long-term results in a...
Eli Lilly Boosts Investment in Indiana Plant to Meet Soaring Drug Demand
$5.3 Billion Expansion to Enhance Supply of Weight Loss and Diabetes Treatments Eli Lilly (LLY) announced a $5.3 billion investment...
Advancing Cancer Therapy: CytomX’s Positive Clinical Data and Future Milestones
Insights into CytomX's Innovative Therapeutic Pipeline and Financial Performance CytomX Therapeutics (CTMX), a pioneering player in the oncology therapeutics domain,...
Amgen’s Obesity Drug Excites Investors as Shares Surge
Positive Early Results Propel Amgen to Compete in Lucrative Weight-Loss Market Amgen (AMGN) experienced a significant surge in its shares...
Pfizer Reports Strong Revenue and Adjusts Profit Outlook, Driven by Cost Cuts and Non-Covid Sales
Pharmaceutical Giant's Performance Signals Recovery Amid Decline in Covid Product Demand Pfizer's (PFE) first-quarter results surpassed expectations, with revenue beating...
Eli Lilly Boosts Sales Forecast as Demand Soars for Weight-Loss Drug Zepbound
Increased Manufacturing Capacity to Address Shortages and Meet Skyrocketing Demand Eli Lilly & Co. (LLY) announced a significant increase in...
Morning Movers: Market Trends and Stocks to Watch
Stay Ahead of the Curve with Today's Top Market Insights and Key Stock Performances Koninklije Philips N.V (PHG) Philips announces...
FDA Approves Pfizer’s Beqvez Gene Therapy for Hemophilia B: A Milestone in Rare Disease Treatment
Pfizer's Breakthrough Therapy Offers Hope to Patients Despite Hefty Price Tag The Food and Drug Administration's approval of Pfizer's (PFE)...
Biodexa’s Acquisition of eRapa Marks Milestone in FAP Treatment Development
Strategic Agreement with Emtora Biosciences Propels Biodexa's Oncology Pipeline Forward with Potential to Transform Treatment Landscape Biodexa Pharmaceuticals PLC (BDRX)...
Merck’s Strong First Quarter Performance Sets Positive Tone Amidst Patent Expiration Preparations
Keytruda Sales Surge and Vaccine Demand Drive Revenue Growth, Signaling Resilience Amidst Looming Challenges Merck (MRK), the pharmaceutical giant, kicked...
